Encorafenib and Binimetinib
(EN-kor-A-feh-nib) and (BIH-nee-MEH-tih-nib)
Braftovi® and Mektovi®
(braf-TOH-vee) and (mek-TOH-vee)
The combination of Encorafenib (Braftovi®) and Binimetinib (Mektovi®) is used to treat patients with melanoma that have a genetic mutation called BRAF V600E or V600K.
Our Medication Sheet
This sheet is available to download as an Adobe PDF.Get Encorafenib and Binimetinib Medication Sheet